Literature DB >> 26287681

Interleukin-21-Producing CD4(+) T Cells Promote Type 2 Immunity to House Dust Mites.

Jonathan M Coquet1, Martijn J Schuijs2, Mark J Smyth3, Kim Deswarte2, Rudi Beyaert4, Harald Braun4, Louis Boon5, Gunilla B Karlsson Hedestam6, Steven L Nutt7, Hamida Hammad8, Bart N Lambrecht9.   

Abstract

Asthma is a T helper 2 (Th2)-cell-mediated disease; however, recent findings implicate Th17 and innate lymphoid cells also in regulating airway inflammation. Herein, we have demonstrated profound interleukin-21 (IL-21) production after house dust mite (HDM)-driven asthma by using T cell receptor (TCR) transgenic mice reactive to Dermatophagoides pteronyssinus 1 and an IL-21GFP reporter mouse. IL-21-producing cells in the mediastinal lymph node (mLN) bore characteristics of T follicular helper (Tfh) cells, whereas IL-21(+) cells in the lung did not express CXCR5 (a chemokine receptor expressed by Tfh cells) and were distinct from effector Th2 or Th17 cells. Il21r(-/-) mice developed reduced type 2 responses and the IL-21 receptor (IL-21R) enhanced Th2 cell function in a cell-intrinsic manner. Finally, administration of recombinant IL-21 and IL-25 synergistically promoted airway eosinophilia primarily via effects on CD4(+) lymphocytes. This highlights an important Th2-cell-amplifying function of IL-21-producing CD4(+) T cells in allergic airway inflammation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26287681     DOI: 10.1016/j.immuni.2015.07.015

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  64 in total

Review 1.  CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.

Authors:  Kiyoshi Hirahara; Toshinori Nakayama
Journal:  Int Immunol       Date:  2016-02-12       Impact factor: 4.823

Review 2.  Professional and 'Amateur' Antigen-Presenting Cells In Type 2 Immunity.

Authors:  Martijn J Schuijs; Hamida Hammad; Bart N Lambrecht
Journal:  Trends Immunol       Date:  2018-11-27       Impact factor: 16.687

Review 3.  Do Memory CD4 T Cells Keep Their Cell-Type Programming: Plasticity versus Fate Commitment? Complexities of Interpretation due to the Heterogeneity of Memory CD4 T Cells, Including T Follicular Helper Cells.

Authors:  Shane Crotty
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

Review 4.  Immune modules shared by innate lymphoid cells and T cells.

Authors:  Michelle L Robinette; Marco Colonna
Journal:  J Allergy Clin Immunol       Date:  2016-11       Impact factor: 10.793

Review 5.  Pathogenic CD4+ T cells in patients with asthma.

Authors:  Lyndsey M Muehling; Monica G Lawrence; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2017-04-22       Impact factor: 10.793

6.  Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells.

Authors:  Véronique Schulten; Victoria Tripple; Grégory Seumois; Yu Qian; Richard H Scheuermann; Zheng Fu; Michela Locci; Sandy Rosales; Pandurangan Vijayanand; Alessandro Sette; Rafeul Alam; Shane Crotty; Bjoern Peters
Journal:  J Allergy Clin Immunol       Date:  2017-05-12       Impact factor: 10.793

Review 7.  Compartmentalization of dendritic cell and T-cell interactions in the lymph node: Anatomy of T-cell fate decisions.

Authors:  Beatriz León; Frances E Lund
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

8.  Asthma at the 2016 American Thoracic Society International Conference.

Authors:  Daniel R Crouch; Praveen Akuthota
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

9.  Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3-CD8+ T cells.

Authors:  Sisi Deng; Zhichen Sun; Jian Qiao; Yong Liang; Longchao Liu; Chunbo Dong; Aijun Shen; Yang Wang; Hong Tang; Yang-Xin Fu; Hua Peng
Journal:  JCI Insight       Date:  2020-04-09

Review 10.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.